Ligand-independent and agonist-mediated degradation of estrogen receptor-α in breast carcinoma cells:: evidence for distinct degradative pathways

被引:23
作者
Nonclercq, D
Journé, F
Body, JJ
Leclercq, G
Laurent, G
机构
[1] Univ Mons, Fac Med & Pharm, Lab Histol & Expt Cytol, B-7000 Mons, Belgium
[2] Univ Mons, Lab Endocrinol Bone Dis, B-7000 Mons, Belgium
[3] Free Univ Brussels, Inst Jules Bordet, Dept Med, Lab J C Heuson Breast Canc Res, B-1000 Brussels, Belgium
关键词
geldanamycin; Hsp90; IBEP-2; LLnL; MCF-7; MG-132; proteasomes; radicicol; raloxifene; tamoxifen;
D O I
10.1016/j.mce.2004.07.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Molecular chaperones and co-chaperones, such as heat-shock proteins (Hsp's), play a pivotal role in the adequate folding and the stability of steroid hormone receptors. As shown by immunolluorescence staining and immunoblot analysis, the Hsp90 inhibitor radicicol induced a rapid (within hours) depletion of estrogen receptor-alpha (ER) in MCF-7 and IBEP-2 breast carcinoma cells. Inhibition of proteasomes (MG-132, LLnL) or of protein synthesis (cycloheximide), which both suppressed E-2-induced downregulation of ER, failed to modify ER degradation caused by radicicol. On the other hand, partial antiestrogens, such as hydroxytamoxifen (a triphenylethylene) and LY H 7,018 (a benzothiophene) stabilized ER, making it immune to radicicol-induced degradation. Furthermore, radicicol did not interfere with ER upregulation induced by hydroxytamoxifen. Thus, the current study points to possible variation in the mechanism/pathway of ER breakdown. Besides, the protective effect of partial antiestrogens suggests that ER stability'is only compromized by Hsp90 disruption when the receptor is in its native, unliganded form. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 65
页数:13
相关论文
共 54 条
[1]   Proteasome-mediated proteolysis of estrogen receptor: A novel component in autologous down-regulation [J].
Alarid, ET ;
Bakopoulos, N ;
Solodin, N .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (09) :1522-1534
[2]   Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-α protein:: Estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary [J].
Alarid, ET ;
Preisler-Mashek, MT ;
Solodin, NM .
ENDOCRINOLOGY, 2003, 144 (08) :3469-3476
[3]  
Bagatell R, 2001, CLIN CANCER RES, V7, P2076
[4]  
Beliakoff J, 2003, CLIN CANCER RES, V9, P4961
[5]  
Bogyo M, 2002, CURR TOP MICROBIOL, V268, P185
[6]  
Bouhouche-Chatelier H, 2001, CELL STRESS CHAPERON, V6, P297
[7]  
Brohée R, 2000, IN VITRO CELL DEV-AN, V36, P640
[8]   C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation [J].
Cardozo, CP ;
Michaud, C ;
Ost, MC ;
Fliss, AE ;
Yang, E ;
Patterson, C ;
Hall, SJ ;
Caplan, AJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 410 (01) :134-140
[9]   Estrogen receptors and cell proliferation in breast cancer [J].
Ciocca, DR ;
Fanelli, MA .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1997, 8 (08) :313-321
[10]  
Clarke M, 1998, LANCET, V351, P1451